HRL
51
4
PFE
28
2
BAX
36
3
SLG
62
-4
HAS
37
3
SJM
19
-12
EQT
44
-6
LMT
32
2
HUM
48
7
DRI
60
2
HES
65
2
EIX
77
-3
ED
53
-2
FLS
75
2
NWSA
80
18
HCA
48
2
MRK
35
-5
VNO
54
-11
RL
82
3
BDX
52
10
HRL
51
4
PFE
28
2
BAX
36
3
SLG
62
-4
HAS
37
3
SJM
19
-12
EQT
44
-6
LMT
32
2
HUM
48
7
DRI
60
2
HES
65
2
EIX
77
-3
ED
53
-2
FLS
75
2
NWSA
80
18
HCA
48
2
MRK
35
-5
VNO
54
-11
RL
82
3
BDX
52
10
Financhill
Back

IDEXX Laboratories Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49

IDXX
IDEXX Laboratories

Last Price:
421.56
Seasonality Move:
9.43%

7 Day Trial

ALL ACCESS PASS

$ 7

IDEXX Laboratories Price Quote

$421.56
-0.19 (-0.05%)
(Updated: November 30, 2024 at 5:43 AM ET)

IDEXX Laboratories Key Stats

Sell
49
IDEXX Laboratories (IDXX) is a Sell
Day range:
$421.50 - $426.96
52-week range:
$398.50 - $583.39
Dividend yield:
0%
P/E ratio:
41.92
P/S ratio:
9.17
P/B ratio:
21.34%
Volume:
338.6K
Avg. volume:
738K
1-year change:
-9.64%
Market cap:
$34.5B
Revenue:
$3.7B
EPS:
$10.37

How Much Does IDEXX Laboratories Make?

Is IDEXX Laboratories Growing As A Company?

  • What Is IDEXX Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is IDEXX Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.11%

IDEXX Laboratories Stock Price Performance

What Is IDEXX Laboratories 52-Week High & Low?

IDEXX Laboratories Price To Free Cash Flow

Is It Risky To Buy IDEXX Laboratories?

  • How Much Debt Does IDEXX Laboratories Have?
    Total long term debt quarterly is $873.9M
  • How Much Cash Does IDEXX Laboratories Have?
    Cash and short term investments quarterly total is $308.6M
  • What Is IDEXX Laboratories’s Book Value Per Share?
    Book value per share is 19.72

Is IDEXX Laboratories Cash Flow Positive?

  • What Is IDXX Cash Flow From Operations?
    Cash flow from operations (TTM) is $916.8M
  • What Is IDEXX Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$747.1M
  • What Is IDEXX Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$197.7M

IDEXX Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    IDXX return on invested capital is 35.27%
  • What Is IDEXX Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 26.31%
  • What Is IDXX Return On Equity?
    ROE is a measure of profitability and is 57.37%

IDEXX Laboratories Earnings Date & Stock Price

IDEXX Laboratories Competitors

  • Who Are IDEXX Laboratories's Competitors?
    Below is a list of companies who compete with IDEXX Laboratories or are related in some way:
    • Bio-Rad Laboratories Inc (BIO)
    • Boston Scientific Corp (BSX)
    • Haemonetics Corp (HAE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Stryker Corp (SYK)

IDEXX Laboratories Dividend Yield

IDEXX Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 10.67% 4.26%
Revenue: 6.56% -0.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 476.76
Upside from Last Price: 13.04%

Major Shareholders

  • How many IDXX shares are owned by institutional investors?
    123M IDXX shares are owned by institutional investors
  • How many IDXX shares are owned by insiders?
    716.5K IDXX shares are owned by insiders